DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study

Triplet DCF (docetaxel, cisplatin and 5-flurouracil) and doublet CP/CF (carboplatin and paclitaxel/cisplatin and 5-fluorouracil) regimens were prospectively evaluated in advanced squamous anal cell carcinoma (SCCA), and validated as standard treatments. Even though the high efficacy and good toleran...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Stefano, Vendrely, Véronique, Saint, Angélique, André, Thierry, Vaflard, Pauline, Samalin, Emmanuelle, Pernot, Simon, Bouché, Oliver, Zubir, Mustapha, Desrame, Jérôme, de la Fouchardière, Christelle, Smith, Denis, Ghiringhelli, François, Vienot, Angélique, Jacquin, Marion, Klajer, Elodie, Nguyen, Thierry, François, Éric, Taieb, Julien, Le Malicot, Karine, Vernerey, Dewi, Meurisse, Aurélia, Borg, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362607/
https://www.ncbi.nlm.nih.gov/pubmed/37480095
http://dx.doi.org/10.1186/s40164-023-00413-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362607/
https://www.ncbi.nlm.nih.gov/pubmed/37480095
http://dx.doi.org/10.1186/s40164-023-00413-2

Ejemplares similares